ADEOLA AREO: Open Payments
NPI 1538792015 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,178 in 46 payments from 16 companies in 2025. Trend: 2023 $233 · 2024 $1,337 · 2025 $1,178
Food & beverage: $1,178
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $317 |
| ABBVIE INC. | 4 | $104 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $103 |
| Dexcom, Inc. | 4 | $91 |
| Amgen Inc. | 5 | $75 |
| Lilly USA, LLC | 4 | $74 |
| Novo Nordisk Inc | 3 | $71 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $54 |
| PFIZER INC. | 2 | $53 |
| GlaxoSmithKline, LLC. | 3 | $49 |
Products named: BREZTRI, AIRSUPRA, VRAYLAR, Kerendia, Dexcom G6 Transmitter, Ozempic, OTEZLA, CAPLYTA.
Industry payments across TX — which companies pay providers there.
